Understanding the Psychological Impact of COVID-19 Pandemic on Patients With Cancer, Their Caregivers, and Health Care Workers in Singapore.


Journal

JCO global oncology
ISSN: 2687-8941
Titre abrégé: JCO Glob Oncol
Pays: United States
ID NLM: 101760170

Informations de publication

Date de publication:
10 2020
Historique:
entrez: 5 10 2020
pubmed: 6 10 2020
medline: 21 10 2020
Statut: ppublish

Résumé

The coronavirus disease 2019 (COVID-19) pandemic has had a global impact, and Singapore has seen 33,000 confirmed cases. Patients with cancer, their caregivers, and health care workers (HCWs) need to balance the challenges associated with COVID-19 while ensuring that cancer care is not compromised. This study aimed to evaluate the psychological effect of COVID-19 on these groups and the prevalence of burnout among HCWs. A cross-sectional survey of patients, caregivers, and HCWs at the National Cancer Centre Singapore was performed over 17 days during the lockdown. The Generalized Anxiety Disorder-7 and Maslach Burnout Inventory were used to assess for anxiety and burnout, respectively. Self-reported fears related to COVID-19 were collected. A total of 624 patients, 408 caregivers, and 421 HCWs participated in the study, with a response rate of 84%, 88%, and 92% respectively. Sixty-six percent of patients, 72.8% of caregivers, and 41.6% of HCWs reported a high level of fear from COVID-19. The top concern of patients was the wide community spread of COVID-19. Caregivers were primarily worried about patients dying alone. HCWs were most worried about the relatively mild symptoms of COVID-19. The prevalence of anxiety was 19.1%, 22.5%, and 14.0% for patients, caregivers, and HCWs, respectively. Patients who were nongraduates and married, and caregivers who were married were more anxious. The prevalence of burnout in HCWs was 43.5%, with more anxious and fearful HCWs reporting higher burnout rates. Fears and anxiety related to COVID-19 are high. Burnout among HCWs is similar to rates reported prepandemic. An individualized approach to target the specific fears of each group will be crucial to maintain the well-being of these vulnerable groups and prevent burnout of HCWs.

Identifiants

pubmed: 33017179
doi: 10.1200/GO.20.00374
pmc: PMC7640379
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1494-1509

Références

Crit Rev Oncol Hematol. 2010 Aug;75(2):122-37
pubmed: 19604706
Ann Oncol. 2020 May;31(5):553-555
pubmed: 32201224
Br J Cancer. 2015 Mar 31;112 Suppl 1:S92-107
pubmed: 25734382
Infect Control Hosp Epidemiol. 2004 Dec;25(12):1033-41
pubmed: 15636289
Am J Public Health. 2004 Apr;94(4):562-4
pubmed: 15054005
Epidemiol Psichiatr Soc. 2009 Jan-Mar;18(1):23-33
pubmed: 19378696
J Anxiety Disord. 2019 Aug;66:102106
pubmed: 31252250
Lancet Oncol. 2020 Jun;21(6):750-751
pubmed: 32359403
Health Psychol. 2006 Jan;25(1):82-90
pubmed: 16448301
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
JAMA Netw Open. 2020 May 1;3(5):e2010185
pubmed: 32463467
CMAJ. 2003 May 13;168(10):1245-51
pubmed: 12743065
Psychooncology. 2011 May;20(5):559-64
pubmed: 20878862
Environ Monit Assess. 2009 Oct;157(1-4):151-67
pubmed: 18841489
J Pain Symptom Manage. 2020 Jul;60(1):e60-e65
pubmed: 32283221
Mayo Clin Proc. 2015 Dec;90(12):1600-13
pubmed: 26653297
Ann Intern Med. 2020 Jul 21;173(2):100-109
pubmed: 32271861
Oncologist. 2019 Jul;24(7):e480-e489
pubmed: 30568022
Psychol Health. 2001 Sep;16(5):565-82
pubmed: 22804499
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
Lancet Oncol. 2020 May;21(5):629-630
pubmed: 32247319
JAMA Netw Open. 2020 Mar 2;3(3):e203976
pubmed: 32202646
Health Policy. 2007 Oct;83(2-3):375-81
pubmed: 17445942
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714

Auteurs

Kennedy Yao Yi Ng (KYY)

Division of Medical Oncology, National Cancer Centre, Singapore.

Siqin Zhou (S)

Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre, Singapore.

Sze Huey Tan (SH)

Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre, Singapore.
Oncology Academic Clinical Program, Duke-NUS Graduate Medical School, Singapore.

Nur Diana Binte Ishak (NDB)

Division of Medical Oncology, National Cancer Centre, Singapore.

Zack Zhong Sheng Goh (ZZS)

Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.

Zi Yang Chua (ZY)

Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.

Jace Ming Xuan Chia (JMX)

Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.

Ee Ling Chew (EL)

Division of Medical Oncology, National Cancer Centre, Singapore.

Than Shwe (T)

Division of Radiation Oncology, National Cancer Centre, Singapore.

Jacklyn Kah Yeen Mok (JKY)

Division of Radiation Oncology, National Cancer Centre, Singapore.

Shen Si Leong (SS)

Division of Medical Oncology, National Cancer Centre, Singapore.

Joanne Si Ying Lo (JSY)

Division of Medical Oncology, National Cancer Centre, Singapore.

Zoe Li Ting Ang (ZLT)

Division of Medical Oncology, National Cancer Centre, Singapore.

Jo Lene Leow (JL)

Department of Pharmacy, National Cancer Centre, Singapore.

Chanel Wei Jie Lam (CWJ)

Department of Nursing, National Cancer Centre, Singapore.

Jin Wei Kwek (JW)

Division of Oncological Imaging, National Cancer Centre, Singapore.

Rebecca Dent (R)

Division of Medical Oncology, National Cancer Centre, Singapore.

Jeffrey Tuan (J)

Division of Radiation Oncology, National Cancer Centre, Singapore.

Soon Thye Lim (ST)

Division of Medical Oncology, National Cancer Centre, Singapore.
Oncology Academic Clinical Program, Duke-NUS Graduate Medical School, Singapore.

William Ying Khee Hwang (WYK)

Division of Medical Oncology, National Cancer Centre, Singapore.
Oncology Academic Clinical Program, Duke-NUS Graduate Medical School, Singapore.

Konstadina Griva (K)

Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.

Joanne Ngeow (J)

Division of Medical Oncology, National Cancer Centre, Singapore.
Oncology Academic Clinical Program, Duke-NUS Graduate Medical School, Singapore.
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH